Chemical Communications · 2018 · 31 citations · 16 references
Life SciencesMedicinal ChemistryPharmacologyDrug DiscoveryInnate ImmunitySignal TransductionCell Signaling NetworksCytokine Receptor SignalingLigand BindingProtein-ligand DockingToll-like ReceptorsAssayMalignant Breast TumorsNf-κb SignalingSmall-molecule Library DesignStructure-based Lead DiscoveryStructure-based ScreeningStructure-based Target DiscoveryToll-like Receptor Structure
We report herein the identification of urea structure-like small molecules by structure-based virtual screening of 10.5 million compounds. Based on a variety of HEK-Blue hTLRs reporter cell assay results, we validated a TLR1/2-specific small molecule agonist, ZINC666243 (SMU127), with EC50 of 0.55 ± 0.01 μM. SMU127 stimulates NF-κB activation and promotes TNFα secretion in human macrophages and mononuclear cells. Moreover, the in vivo assay indicated that SMU127 could inhibit the growth of breast cancer tumors in BABL/c mice. This work has shown for the first time that a small molecule TLR1/2 agonist can inhibit breast cancer in vivo.
16
Crystal Structure of the TLR1-TLR2 Heterodimer Induced by Binding of a Tri-Acylated Lipopeptide
Mi Sun Jin, Sung Eun Kim, Jin Young Heo et al. · Cell · 2007 · 1.3K citations · Full text
Discovery of Small‐Molecule Inhibitors of the TLR1/TLR2 Complex
Kui Cheng, Xiaohui Wang, Shuting Zhang et al. · Angewandte Chemie International Edition · 2012 · 155 citations